Table of Contents
2019 ਦਾ ਸਰਵਉਤਮ ਇਕੁਇਟੀ ਮਿutਚੁਅਲ ਫੰਡ
ਇਕਵਿਟੀ ਫੰਡ ਉਹ ਉਹ ਹੁੰਦੇ ਹਨ ਜਿਨ੍ਹਾਂ ਦੇ ਇਕੱਠੇ ਕੀਤੇ ਫੰਡ ਦੀ ਰਕਮ ਵੱਖ-ਵੱਖ ਕੰਪਨੀਆਂ ਦੇ ਇਕੁਇਟੀ ਅਤੇ ਇਕੁਇਟੀ ਨਾਲ ਜੁੜੇ ਯੰਤਰਾਂ ਵਿੱਚ ਲਗਾਈ ਜਾਂਦੀ ਹੈ. ਇਕੁਇਟੀ ਫੰਡਾਂ ਨੂੰ ਇੱਕ ਮੱਧਮ ਅਤੇ ਉੱਚ- ਵਾਲੇ ਲੋਕਾਂ ਲਈ ਲੰਬੇ ਸਮੇਂ ਦੇ ਨਿਵੇਸ਼ ਵਿਕਲਪ ਵਜੋਂ ਮੰਨਿਆ ਜਾਂਦਾ ਹੈਜੋਖਮ ਭੁੱਖ. ਇਕਵਿਟੀ ਫੰਡਾਂ ਦੀਆਂ ਕਈ ਕਿਸਮਾਂ ਸ਼ਾਮਲ ਹਨਵੱਡੇ ਕੈਪ ਫੰਡ,ਮਿਡ ਕੈਪ ਫੰਡ,ਸਮਾਲ ਕੈਪ ਫੰਡ,ELSS, ਇਤਆਦਿ. ਸਾਲ 2019 ਵਿਚ, ਇਕਵਿਟੀ ਬਾਜ਼ਾਰਾਂ ਵਿਚ ਉਛਾਲ ਦੇਖਣ ਨੂੰ ਮਿਲਿਆ ਜਿਸ ਕਾਰਨ ਜ਼ਿਆਦਾਤਰ ਇਕਵਿਟੀ ਫੰਡ ਸ਼੍ਰੇਣੀਆਂ ਨੇ ਵਧੀਆ ਪ੍ਰਦਰਸ਼ਨ ਕੀਤਾ. ਇਨ੍ਹਾਂ ਫੰਡਾਂ ਦੀ ਕਾਰਗੁਜ਼ਾਰੀ ਬਹੁਤ ਸਾਰੇ ਮੈਕਰੋ ਅਤੇ ਮਾਈਕਰੋਕੋਮੋਨਿਕ ਮਾਪਦੰਡਾਂ 'ਤੇ ਨਿਰਭਰ ਕਰਦੀ ਹੈ ਜਿਵੇਂ ਕਿ ਉਦਯੋਗ ਦੀ ਕਾਰਗੁਜ਼ਾਰੀ, ਕੰਪਨੀ ਦੀ ਕਾਰਗੁਜ਼ਾਰੀ, ਕਮਾਈ ਅਤੇ ਕੰਪਨੀਆਂ ਦੀ ਮੁਨਾਫਾ, ਇਸ ਦੀਆਂ ਭਵਿੱਖ ਦੀਆਂ ਸੰਭਾਵਨਾਵਾਂ ਅਤੇ ਹੋਰ. ਚੋਟੀ ਅਤੇਸਰਬੋਤਮ ਇਕੁਇਟੀ ਫੰਡ ਸਾਲ 2019 ਲਈ ਹੇਠ ਦਿੱਤੇ ਅਨੁਸਾਰ ਹਨ.
Talk to our investment specialist
ਪ੍ਰਦਰਸ਼ਨ ਦੇ ਅਧਾਰ ਤੇ 2019 ਦੇ ਚੋਟੀ ਦੇ 10 ਇਕੁਇਟੀ ਮਿutਚੁਅਲ ਫੰਡ
Fund NAV Net Assets (Cr) 2024 (%) 2023 (%) 2022 (%) 2021 (%) 2020 (%) Motilal Oswal Midcap 30 Fund Growth ₹102.765
↓ -0.25 ₹33,053 57.1 41.7 10.7 55.8 9.3 LIC MF Infrastructure Fund Growth ₹49.1858
↓ -0.18 ₹1,053 47.8 44.4 7.9 46.6 -0.1 Motilal Oswal Long Term Equity Fund Growth ₹51.6259
↓ -0.31 ₹4,506 47.7 37 1.8 32.1 8.8 Motilal Oswal Multicap 35 Fund Growth ₹62.2158
↑ 0.08 ₹13,894 45.7 31 -3 15.3 10.3 Invesco India Mid Cap Fund Growth ₹178.29
↓ -0.68 ₹7,406 43.1 34.1 0.5 43.1 24.4 UTI Healthcare Fund Growth ₹290.686
↓ -1.43 ₹1,099 42.9 38.2 -12.3 19.1 67.4 SBI Healthcare Opportunities Fund Growth ₹434.72
↑ 2.09 ₹3,849 42.2 38.2 -6 20.1 65.8 TATA India Pharma & Healthcare Fund Growth ₹30.52
↓ -0.06 ₹1,282 40.4 36.6 -8 19.1 64.4 IDBI Small Cap Fund Growth ₹29.9588
↓ -0.21 ₹605 40 33.4 2.4 64.7 19 L&T Midcap Fund Growth ₹388.377
↑ 0.23 ₹12,146 39.7 40 1.1 30.4 19 Note: Returns up to 1 year are on absolute basis & more than 1 year are on CAGR basis. as on 5 Aug 25
2019 ਦੇ ਚੋਟੀ ਦੇ ਅਤੇ ਸਰਬੋਤਮ ਇਕੁਇਟੀ ਮਿutਚੁਅਲ ਫੰਡ
(Erstwhile Motilal Oswal MOSt Focused Midcap 30 Fund) The investment objective of the Scheme is to achieve long term capital appreciation by investing in a maximum of 30 quality mid-cap companies having long-term competitive advantages and potential for growth. However, there can be no assurance or guarantee that the investment objective of the Scheme would be achieved. Motilal Oswal Midcap 30 Fund is a Equity - Mid Cap fund was launched on 24 Feb 14. It is a fund with Moderately High risk and has given a Below is the key information for Motilal Oswal Midcap 30 Fund Returns up to 1 year are on The investment objective of the scheme is to provide long term growth from a portfolio of equity / equity related instruments of companies engaged either directly or indirectly in the infrastructure sector. LIC MF Infrastructure Fund is a Equity - Sectoral fund was launched on 29 Feb 08. It is a fund with High risk and has given a Below is the key information for LIC MF Infrastructure Fund Returns up to 1 year are on (Erstwhile Motilal Oswal MOSt Focused Long Term Fund) The investment objective of the Scheme is to generate long-term capital appreciation from a diversified portfolio of predominantly equity and equity related instruments. However, there can be no assurance or guarantee that the investment objective of the Scheme would be achieved. Motilal Oswal Long Term Equity Fund is a Equity - ELSS fund was launched on 21 Jan 15. It is a fund with Moderately High risk and has given a Below is the key information for Motilal Oswal Long Term Equity Fund Returns up to 1 year are on (Erstwhile Motilal Oswal MOSt Focused Multicap 35 Fund) The investment objective of the Scheme is to achieve long term capital appreciation by primarily investing in a maximum of 35 equity & equity related instruments across sectors and market-capitalization levels.However, there can be no assurance or guarantee that the investment objective of the Scheme would be achieved. Motilal Oswal Multicap 35 Fund is a Equity - Multi Cap fund was launched on 28 Apr 14. It is a fund with Moderately High risk and has given a Below is the key information for Motilal Oswal Multicap 35 Fund Returns up to 1 year are on The Scheme seeks to provide long term capital appreciation by investing in a portfolio that is predominantly constituted of equity and equity related instruments of mid cap companies. However, there can be no assurance that the funds objectives will be achieved. Invesco India Mid Cap Fund is a Equity - Mid Cap fund was launched on 19 Apr 07. It is a fund with Moderately High risk and has given a Below is the key information for Invesco India Mid Cap Fund Returns up to 1 year are on (Erstwhile UTI Pharma & Healthcare Fund) The Investment objective of the Scheme is capital appreciation through investments in equities and equity related instruments of the Pharma & Healthcare sectors. UTI Healthcare Fund is a Equity - Sectoral fund was launched on 28 Jun 99. It is a fund with High risk and has given a Below is the key information for UTI Healthcare Fund Returns up to 1 year are on (Erstwhile SBI Pharma Fund) To provide the investors maximum growth opportunity through equity
investments in stocks of growth oriented sectors of the economy. SBI Healthcare Opportunities Fund is a Equity - Sectoral fund was launched on 31 Dec 04. It is a fund with High risk and has given a Below is the key information for SBI Healthcare Opportunities Fund Returns up to 1 year are on The investment objective of the scheme is to seek long term capital appreciation by investing atleast 80% of its net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved.The Scheme does not assure or guarantee any returns. TATA India Pharma & Healthcare Fund is a Equity - Sectoral fund was launched on 28 Dec 15. It is a fund with High risk and has given a Below is the key information for TATA India Pharma & Healthcare Fund Returns up to 1 year are on The Investment objective of the Scheme is to provide investors with the opportunities for long-term capital appreciation by investing predominantly in Equity and Equity related instruments of Small Cap companies. However
there can be no assurance that the investment objective under the Scheme will be realized. IDBI Small Cap Fund is a Equity - Small Cap fund was launched on 21 Jun 17. It is a fund with Moderately High risk and has given a Below is the key information for IDBI Small Cap Fund Returns up to 1 year are on To generate capital appreciation by investing primarily in midcap stocks. The scheme will invest primarily in companies whose market capitalization falls between the highest and the lowest constituent of the Nifty Free Float Midcap 100. L&T Midcap Fund is a Equity - Mid Cap fund was launched on 9 Aug 04. It is a fund with High risk and has given a Below is the key information for L&T Midcap Fund Returns up to 1 year are on 1. Motilal Oswal Midcap 30 Fund
CAGR/Annualized return of 22.6% since its launch. Ranked 27 in Mid Cap category. Return for 2024 was 57.1% , 2023 was 41.7% and 2022 was 10.7% . Motilal Oswal Midcap 30 Fund
Growth Launch Date 24 Feb 14 NAV (05 Aug 25) ₹102.765 ↓ -0.25 (-0.24 %) Net Assets (Cr) ₹33,053 on 30 Jun 25 Category Equity - Mid Cap AMC Motilal Oswal Asset Management Co. Ltd Rating ☆☆☆ Risk Moderately High Expense Ratio 0.66 Sharpe Ratio 0.23 Information Ratio 0.44 Alpha Ratio 3.89 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value 31 Jul 20 ₹10,000 31 Jul 21 ₹16,540 31 Jul 22 ₹20,655 31 Jul 23 ₹26,047 31 Jul 24 ₹44,147 31 Jul 25 ₹44,850 Returns for Motilal Oswal Midcap 30 Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 5 Aug 25 Duration Returns 1 Month -0.9% 3 Month 6.9% 6 Month 4.8% 1 Year 6.4% 3 Year 28.9% 5 Year 34.5% 10 Year 15 Year Since launch 22.6% Historical performance (Yearly) on absolute basis
Year Returns 2024 57.1% 2023 41.7% 2022 10.7% 2021 55.8% 2020 9.3% 2019 9.7% 2018 -12.7% 2017 30.8% 2016 5.2% 2015 16.5% Fund Manager information for Motilal Oswal Midcap 30 Fund
Name Since Tenure Ajay Khandelwal 1 Oct 24 0.83 Yr. Niket Shah 1 Jul 20 5.09 Yr. Rakesh Shetty 22 Nov 22 2.69 Yr. Sunil Sawant 1 Jul 24 1.08 Yr. Data below for Motilal Oswal Midcap 30 Fund as on 30 Jun 25
Equity Sector Allocation
Sector Value Technology 33.7% Industrials 18.11% Consumer Cyclical 17.65% Health Care 4.49% Communication Services 3.99% Real Estate 2.83% Financial Services 2.61% Asset Allocation
Asset Class Value Cash 17.17% Equity 82.83% Top Securities Holdings / Portfolio
Name Holding Value Quantity Coforge Ltd (Technology)
Equity, Since 31 Mar 23 | COFORGE10% ₹3,464 Cr 18,000,000 Persistent Systems Ltd (Technology)
Equity, Since 31 Jan 23 | PERSISTENT10% ₹3,172 Cr 5,250,000 Trent Ltd (Consumer Cyclical)
Equity, Since 30 Nov 24 | 5002519% ₹3,104 Cr 4,992,139
↑ 2,848,945 Dixon Technologies (India) Ltd (Technology)
Equity, Since 31 Mar 23 | DIXON9% ₹2,997 Cr 1,999,999
↑ 1,164,799 Kalyan Jewellers India Ltd (Consumer Cyclical)
Equity, Since 29 Feb 24 | KALYANKJIL8% ₹2,501 Cr 45,000,000
↑ 1,509,750 Polycab India Ltd (Industrials)
Equity, Since 30 Sep 23 | POLYCAB5% ₹1,671 Cr 2,550,000
↑ 50,000 KEI Industries Ltd (Industrials)
Equity, Since 30 Nov 24 | KEI4% ₹1,327 Cr 3,500,000
↑ 750,000 Bharti Hexacom Ltd (Communication Services)
Equity, Since 31 Oct 24 | BHARTIHEXA4% ₹1,318 Cr 6,750,000 Max Healthcare Institute Ltd Ordinary Shares (Healthcare)
Equity, Since 31 Mar 24 | MAXHEALTH4% ₹1,272 Cr 9,969,361 Kaynes Technology India Ltd (Industrials)
Equity, Since 30 Jun 25 | KAYNES3% ₹975 Cr 1,599,306
↑ 1,599,306 2. LIC MF Infrastructure Fund
CAGR/Annualized return of 9.6% since its launch. Return for 2024 was 47.8% , 2023 was 44.4% and 2022 was 7.9% . LIC MF Infrastructure Fund
Growth Launch Date 29 Feb 08 NAV (05 Aug 25) ₹49.1858 ↓ -0.18 (-0.36 %) Net Assets (Cr) ₹1,053 on 30 Jun 25 Category Equity - Sectoral AMC LIC Mutual Fund Asset Mgmt Co Ltd Rating Risk High Expense Ratio 2.3 Sharpe Ratio -0.02 Information Ratio 0.45 Alpha Ratio 0.77 Min Investment 5,000 Min SIP Investment 1,000 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value 31 Jul 20 ₹10,000 31 Jul 21 ₹16,221 31 Jul 22 ₹18,685 31 Jul 23 ₹23,092 31 Jul 24 ₹42,743 31 Jul 25 ₹40,588 Returns for LIC MF Infrastructure Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 5 Aug 25 Duration Returns 1 Month -2.8% 3 Month 11.7% 6 Month 8.7% 1 Year -1.5% 3 Year 28.7% 5 Year 32% 10 Year 15 Year Since launch 9.6% Historical performance (Yearly) on absolute basis
Year Returns 2024 47.8% 2023 44.4% 2022 7.9% 2021 46.6% 2020 -0.1% 2019 13.3% 2018 -14.6% 2017 42.2% 2016 -2.2% 2015 -6.2% Fund Manager information for LIC MF Infrastructure Fund
Name Since Tenure Yogesh Patil 18 Sep 20 4.87 Yr. Mahesh Bendre 1 Jul 24 1.08 Yr. Data below for LIC MF Infrastructure Fund as on 30 Jun 25
Equity Sector Allocation
Sector Value Industrials 48.17% Basic Materials 9.22% Financial Services 6.64% Utility 6.09% Consumer Cyclical 5.19% Technology 4.23% Real Estate 3.53% Health Care 3.22% Communication Services 2.53% Energy 0.91% Asset Allocation
Asset Class Value Cash 9.35% Equity 89.72% Debt 0.93% Other 0% Top Securities Holdings / Portfolio
Name Holding Value Quantity Shakti Pumps (India) Ltd (Industrials)
Equity, Since 31 Mar 24 | SHAKTIPUMP4% ₹45 Cr 475,992
↑ 23,420 Garware Hi-Tech Films Ltd (Basic Materials)
Equity, Since 31 Aug 23 | 5006554% ₹40 Cr 94,287 Larsen & Toubro Ltd (Industrials)
Equity, Since 30 Apr 09 | LT4% ₹38 Cr 103,491
↑ 47,984 LIC MF Money Market Dir Gr
Investment Fund | -3% ₹35 Cr 290,520
↑ 290,520 Afcons Infrastructure Ltd (Industrials)
Equity, Since 31 Oct 24 | AFCONS3% ₹34 Cr 769,765
↑ 145,330 Tata Power Co Ltd (Utilities)
Equity, Since 29 Feb 24 | 5004003% ₹29 Cr 724,927 Apollo Hospitals Enterprise Ltd (Healthcare)
Equity, Since 30 Jun 25 | APOLLOHOSP3% ₹29 Cr 39,867
↑ 39,867 Avalon Technologies Ltd (Technology)
Equity, Since 31 Jul 23 | AVALON3% ₹27 Cr 317,486
↑ 179,935 Schneider Electric Infrastructure Ltd (Industrials)
Equity, Since 31 Dec 23 | 5341393% ₹27 Cr 319,302
↑ 13,378 REC Ltd (Financial Services)
Equity, Since 31 Jul 23 | 5329552% ₹25 Cr 621,524
↑ 50,192 3. Motilal Oswal Long Term Equity Fund
CAGR/Annualized return of 16.9% since its launch. Return for 2024 was 47.7% , 2023 was 37% and 2022 was 1.8% . Motilal Oswal Long Term Equity Fund
Growth Launch Date 21 Jan 15 NAV (05 Aug 25) ₹51.6259 ↓ -0.31 (-0.60 %) Net Assets (Cr) ₹4,506 on 30 Jun 25 Category Equity - ELSS AMC Motilal Oswal Asset Management Co. Ltd Rating Risk Moderately High Expense Ratio 0.74 Sharpe Ratio 0.26 Information Ratio 1.02 Alpha Ratio 6.93 Min Investment 500 Min SIP Investment 500 Exit Load NIL Growth of 10,000 investment over the years.
Date Value 31 Jul 20 ₹10,000 31 Jul 21 ₹15,917 31 Jul 22 ₹15,790 31 Jul 23 ₹19,504 31 Jul 24 ₹31,082 31 Jul 25 ₹32,246 Returns for Motilal Oswal Long Term Equity Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 5 Aug 25 Duration Returns 1 Month -2.2% 3 Month 9.7% 6 Month 7.2% 1 Year 7.8% 3 Year 25.9% 5 Year 26% 10 Year 15 Year Since launch 16.9% Historical performance (Yearly) on absolute basis
Year Returns 2024 47.7% 2023 37% 2022 1.8% 2021 32.1% 2020 8.8% 2019 13.2% 2018 -8.7% 2017 44% 2016 12.5% 2015 Fund Manager information for Motilal Oswal Long Term Equity Fund
Name Since Tenure Ajay Khandelwal 11 Dec 23 1.64 Yr. Rakesh Shetty 22 Nov 22 2.69 Yr. Atul Mehra 1 Oct 24 0.83 Yr. Data below for Motilal Oswal Long Term Equity Fund as on 30 Jun 25
Equity Sector Allocation
Sector Value Industrials 35.64% Financial Services 20.78% Consumer Cyclical 18.73% Technology 10.72% Basic Materials 5.55% Real Estate 3.88% Health Care 3.27% Communication Services 0.61% Asset Allocation
Asset Class Value Cash 0.81% Equity 99.19% Top Securities Holdings / Portfolio
Name Holding Value Quantity Eternal Ltd (Consumer Cyclical)
Equity, Since 31 Oct 23 | 5433205% ₹237 Cr 8,970,581
↓ -953,111 Multi Commodity Exchange of India Ltd (Financial Services)
Equity, Since 29 Feb 24 | MCX5% ₹222 Cr 248,438
↑ 13,355 Trent Ltd (Consumer Cyclical)
Equity, Since 31 Aug 22 | 5002515% ₹214 Cr 344,266
↓ -80,994 Bharat Dynamics Ltd Ordinary Shares (Industrials)
Equity, Since 31 Dec 23 | BDL5% ₹205 Cr 1,056,315 Kaynes Technology India Ltd (Industrials)
Equity, Since 30 Jun 23 | KAYNES4% ₹181 Cr 297,751 Prestige Estates Projects Ltd (Real Estate)
Equity, Since 31 Oct 23 | PRESTIGE4% ₹175 Cr 1,055,205 Suzlon Energy Ltd (Industrials)
Equity, Since 31 Jan 24 | SUZLON4% ₹167 Cr 24,702,337 Bharat Electronics Ltd (Industrials)
Equity, Since 30 Apr 24 | BEL4% ₹166 Cr 3,950,000 Amber Enterprises India Ltd Ordinary Shares (Consumer Cyclical)
Equity, Since 31 Mar 24 | AMBER4% ₹163 Cr 240,350 Waaree Energies Ltd (Technology)
Equity, Since 31 Oct 24 | 5442773% ₹153 Cr 487,045
↑ 28,725 4. Motilal Oswal Multicap 35 Fund
CAGR/Annualized return of 17.6% since its launch. Ranked 5 in Multi Cap category. Return for 2024 was 45.7% , 2023 was 31% and 2022 was -3% . Motilal Oswal Multicap 35 Fund
Growth Launch Date 28 Apr 14 NAV (05 Aug 25) ₹62.2158 ↑ 0.08 (0.12 %) Net Assets (Cr) ₹13,894 on 30 Jun 25 Category Equity - Multi Cap AMC Motilal Oswal Asset Management Co. Ltd Rating ☆☆☆☆☆ Risk Moderately High Expense Ratio 0.94 Sharpe Ratio 0.42 Information Ratio 0.73 Alpha Ratio 8.72 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value 31 Jul 20 ₹10,000 31 Jul 21 ₹13,752 31 Jul 22 ₹12,839 31 Jul 23 ₹14,742 31 Jul 24 ₹23,209 31 Jul 25 ₹24,769 Returns for Motilal Oswal Multicap 35 Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 5 Aug 25 Duration Returns 1 Month -1.1% 3 Month 6.9% 6 Month 7.4% 1 Year 12% 3 Year 24.2% 5 Year 19.7% 10 Year 15 Year Since launch 17.6% Historical performance (Yearly) on absolute basis
Year Returns 2024 45.7% 2023 31% 2022 -3% 2021 15.3% 2020 10.3% 2019 7.9% 2018 -7.8% 2017 43.1% 2016 8.5% 2015 14.6% Fund Manager information for Motilal Oswal Multicap 35 Fund
Name Since Tenure Ajay Khandelwal 1 Oct 24 0.83 Yr. Niket Shah 1 Jul 22 3.09 Yr. Rakesh Shetty 22 Nov 22 2.69 Yr. Atul Mehra 1 Oct 24 0.83 Yr. Sunil Sawant 1 Jul 24 1.08 Yr. Data below for Motilal Oswal Multicap 35 Fund as on 30 Jun 25
Equity Sector Allocation
Sector Value Technology 29.47% Industrials 20.13% Consumer Cyclical 16.61% Communication Services 8.69% Financial Services 8.11% Utility 5.25% Health Care 1.84% Asset Allocation
Asset Class Value Cash 9.92% Equity 90.08% Top Securities Holdings / Portfolio
Name Holding Value Quantity Coforge Ltd (Technology)
Equity, Since 31 May 23 | COFORGE11% ₹1,564 Cr 8,125,000 Persistent Systems Ltd (Technology)
Equity, Since 31 Mar 23 | PERSISTENT10% ₹1,329 Cr 2,200,000 Polycab India Ltd (Industrials)
Equity, Since 31 Jan 24 | POLYCAB9% ₹1,310 Cr 2,000,000
↑ 57,695 Trent Ltd (Consumer Cyclical)
Equity, Since 31 Jan 23 | 5002519% ₹1,244 Cr 2,000,000
↑ 605,111 Kalyan Jewellers India Ltd (Consumer Cyclical)
Equity, Since 30 Sep 23 | KALYANKJIL7% ₹1,001 Cr 18,000,000 Dixon Technologies (India) Ltd (Technology)
Equity, Since 31 Mar 25 | DIXON7% ₹936 Cr 625,000
↑ 611,700 CG Power & Industrial Solutions Ltd (Industrials)
Equity, Since 31 Jan 25 | 5000936% ₹836 Cr 12,250,000 Bharti Airtel Ltd (Partly Paid Rs.1.25) (Communication Services)
Equity, Since 30 Apr 24 | 8901576% ₹765 Cr 4,999,500 Cholamandalam Investment and Finance Co Ltd (Financial Services)
Equity, Since 31 Mar 23 | CHOLAFIN5% ₹733 Cr 4,500,000 Siemens Energy India Ltd (Utilities)
Equity, Since 30 Jun 25 | ENRIN5% ₹729 Cr 2,450,500
↑ 2,450,500 5. Invesco India Mid Cap Fund
CAGR/Annualized return of 17.1% since its launch. Ranked 38 in Mid Cap category. Return for 2024 was 43.1% , 2023 was 34.1% and 2022 was 0.5% . Invesco India Mid Cap Fund
Growth Launch Date 19 Apr 07 NAV (05 Aug 25) ₹178.29 ↓ -0.68 (-0.38 %) Net Assets (Cr) ₹7,406 on 30 Jun 25 Category Equity - Mid Cap AMC Invesco Asset Management (India) Private Ltd Rating ☆☆ Risk Moderately High Expense Ratio 1.89 Sharpe Ratio 0.54 Information Ratio 0 Alpha Ratio 0 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value 31 Jul 20 ₹10,000 31 Jul 21 ₹16,599 31 Jul 22 ₹16,962 31 Jul 23 ₹20,915 31 Jul 24 ₹32,452 31 Jul 25 ₹36,233 Returns for Invesco India Mid Cap Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 5 Aug 25 Duration Returns 1 Month -0.7% 3 Month 11.6% 6 Month 12.2% 1 Year 17.1% 3 Year 27.9% 5 Year 28.9% 10 Year 15 Year Since launch 17.1% Historical performance (Yearly) on absolute basis
Year Returns 2024 43.1% 2023 34.1% 2022 0.5% 2021 43.1% 2020 24.4% 2019 3.8% 2018 -5.3% 2017 44.3% 2016 1.1% 2015 6.4% Fund Manager information for Invesco India Mid Cap Fund
Name Since Tenure Aditya Khemani 9 Nov 23 1.73 Yr. Amit Ganatra 1 Sep 23 1.92 Yr. Data below for Invesco India Mid Cap Fund as on 30 Jun 25
Equity Sector Allocation
Sector Value Financial Services 26.6% Health Care 18.98% Consumer Cyclical 17.09% Industrials 12.25% Technology 8.31% Real Estate 7.93% Basic Materials 5.97% Communication Services 1.86% Asset Allocation
Asset Class Value Cash 0.96% Equity 99.04% Top Securities Holdings / Portfolio
Name Holding Value Quantity BSE Ltd (Financial Services)
Equity, Since 31 Dec 23 | BSE6% ₹421 Cr 1,519,233 L&T Finance Ltd (Financial Services)
Equity, Since 31 Dec 23 | LTF5% ₹347 Cr 16,854,973 Prestige Estates Projects Ltd (Real Estate)
Equity, Since 30 Nov 23 | PRESTIGE5% ₹337 Cr 2,031,622
↑ 138,005 Swiggy Ltd (Consumer Cyclical)
Equity, Since 30 Nov 24 | SWIGGY4% ₹312 Cr 7,797,891
↑ 1,783,049 Max Financial Services Ltd (Financial Services)
Equity, Since 30 Nov 23 | 5002714% ₹303 Cr 1,842,058
↑ 43,526 Glenmark Pharmaceuticals Ltd (Healthcare)
Equity, Since 31 Mar 24 | 5322964% ₹294 Cr 1,676,417
↑ 274,220 Max Healthcare Institute Ltd Ordinary Shares (Healthcare)
Equity, Since 31 Dec 22 | MAXHEALTH4% ₹287 Cr 2,246,434 The Federal Bank Ltd (Financial Services)
Equity, Since 31 Oct 22 | FEDERALBNK4% ₹286 Cr 13,411,587
↑ 665,645 Trent Ltd (Consumer Cyclical)
Equity, Since 30 Apr 21 | 5002514% ₹274 Cr 441,151 JK Cement Ltd (Basic Materials)
Equity, Since 31 Oct 22 | JKCEMENT4% ₹265 Cr 431,234 6. UTI Healthcare Fund
CAGR/Annualized return of 15% since its launch. Ranked 40 in Sectoral category. Return for 2024 was 42.9% , 2023 was 38.2% and 2022 was -12.3% . UTI Healthcare Fund
Growth Launch Date 28 Jun 99 NAV (05 Aug 25) ₹290.686 ↓ -1.43 (-0.49 %) Net Assets (Cr) ₹1,099 on 30 Jun 25 Category Equity - Sectoral AMC UTI Asset Management Company Ltd Rating ☆ Risk High Expense Ratio 2.38 Sharpe Ratio 0.75 Information Ratio -0.29 Alpha Ratio 1.14 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value 31 Jul 20 ₹10,000 31 Jul 21 ₹14,212 31 Jul 22 ₹12,434 31 Jul 23 ₹15,086 31 Jul 24 ₹22,089 31 Jul 25 ₹25,028 Returns for UTI Healthcare Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 5 Aug 25 Duration Returns 1 Month 0.1% 3 Month 7.1% 6 Month 4.6% 1 Year 12.3% 3 Year 25.1% 5 Year 19.1% 10 Year 15 Year Since launch 15% Historical performance (Yearly) on absolute basis
Year Returns 2024 42.9% 2023 38.2% 2022 -12.3% 2021 19.1% 2020 67.4% 2019 1.2% 2018 -7.5% 2017 6.2% 2016 -9.7% 2015 12.4% Fund Manager information for UTI Healthcare Fund
Name Since Tenure Kamal Gada 2 May 22 3.25 Yr. Data below for UTI Healthcare Fund as on 30 Jun 25
Equity Sector Allocation
Sector Value Health Care 97.97% Basic Materials 0.93% Asset Allocation
Asset Class Value Cash 1.1% Equity 98.9% Top Securities Holdings / Portfolio
Name Holding Value Quantity Sun Pharmaceuticals Industries Ltd (Healthcare)
Equity, Since 31 Oct 06 | SUNPHARMA10% ₹111 Cr 661,016 Cipla Ltd (Healthcare)
Equity, Since 31 Jan 03 | 5000875% ₹60 Cr 400,000 Ajanta Pharma Ltd (Healthcare)
Equity, Since 31 Jul 17 | 5323315% ₹54 Cr 210,000
↑ 37,171 Procter & Gamble Health Ltd (Healthcare)
Equity, Since 31 Dec 20 | PGHL4% ₹47 Cr 80,283 Dr Reddy's Laboratories Ltd (Healthcare)
Equity, Since 28 Feb 18 | DRREDDY4% ₹46 Cr 360,000
↓ -36,000 Glenmark Pharmaceuticals Ltd (Healthcare)
Equity, Since 31 Mar 24 | 5322964% ₹44 Cr 250,000
↓ -25,250 Lupin Ltd (Healthcare)
Equity, Since 28 Feb 25 | 5002574% ₹39 Cr 200,000
↑ 60,000 Apollo Hospitals Enterprise Ltd (Healthcare)
Equity, Since 30 Apr 21 | APOLLOHOSP3% ₹38 Cr 53,000
↓ -3,271 Divi's Laboratories Ltd (Healthcare)
Equity, Since 30 Sep 17 | DIVISLAB3% ₹38 Cr 56,000 Fortis Healthcare Ltd (Healthcare)
Equity, Since 31 Dec 20 | 5328433% ₹37 Cr 465,000 7. SBI Healthcare Opportunities Fund
CAGR/Annualized return of 15.6% since its launch. Ranked 34 in Sectoral category. Return for 2024 was 42.2% , 2023 was 38.2% and 2022 was -6% . SBI Healthcare Opportunities Fund
Growth Launch Date 31 Dec 04 NAV (04 Aug 25) ₹434.72 ↑ 2.09 (0.48 %) Net Assets (Cr) ₹3,849 on 30 Jun 25 Category Equity - Sectoral AMC SBI Funds Management Private Limited Rating ☆☆ Risk High Expense Ratio 2.09 Sharpe Ratio 0.87 Information Ratio 0.37 Alpha Ratio 2.79 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-15 Days (0.5%),15 Days and above(NIL) Growth of 10,000 investment over the years.
Date Value 31 Jul 20 ₹10,000 31 Jul 21 ₹14,418 31 Jul 22 ₹12,951 31 Jul 23 ₹16,915 31 Jul 24 ₹23,551 31 Jul 25 ₹27,155 Returns for SBI Healthcare Opportunities Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 5 Aug 25 Duration Returns 1 Month -0.6% 3 Month 3.9% 6 Month 3% 1 Year 13.3% 3 Year 27% 5 Year 21.3% 10 Year 15 Year Since launch 15.6% Historical performance (Yearly) on absolute basis
Year Returns 2024 42.2% 2023 38.2% 2022 -6% 2021 20.1% 2020 65.8% 2019 -0.5% 2018 -9.9% 2017 2.1% 2016 -14% 2015 27.1% Fund Manager information for SBI Healthcare Opportunities Fund
Name Since Tenure Tanmaya Desai 1 Jun 11 14.18 Yr. Data below for SBI Healthcare Opportunities Fund as on 30 Jun 25
Equity Sector Allocation
Sector Value Health Care 91.24% Basic Materials 5.74% Asset Allocation
Asset Class Value Cash 2.94% Equity 96.98% Debt 0.08% Top Securities Holdings / Portfolio
Name Holding Value Quantity Sun Pharmaceuticals Industries Ltd (Healthcare)
Equity, Since 31 Dec 17 | SUNPHARMA12% ₹469 Cr 2,800,000 Divi's Laboratories Ltd (Healthcare)
Equity, Since 31 Mar 12 | DIVISLAB8% ₹300 Cr 440,000
↑ 27,778 Max Healthcare Institute Ltd Ordinary Shares (Healthcare)
Equity, Since 31 Mar 21 | MAXHEALTH7% ₹268 Cr 2,100,000 Lonza Group Ltd ADR (Healthcare)
Equity, Since 31 Jan 24 | LO3A5% ₹183 Cr 300,000 Cipla Ltd (Healthcare)
Equity, Since 31 Aug 16 | 5000875% ₹181 Cr 1,200,000 Lupin Ltd (Healthcare)
Equity, Since 31 Aug 23 | 5002574% ₹163 Cr 840,000 Mankind Pharma Ltd (Healthcare)
Equity, Since 30 Apr 23 | MANKIND3% ₹130 Cr 560,000 Abbott India Ltd (Healthcare)
Equity, Since 31 Mar 19 | ABBOTINDIA3% ₹128 Cr 36,000 Fortis Healthcare Ltd (Healthcare)
Equity, Since 30 Apr 21 | 5328433% ₹127 Cr 1,600,000
↓ -80,000 Aster DM Healthcare Ltd Ordinary Shares (Healthcare)
Equity, Since 31 Mar 24 | 5409753% ₹125 Cr 2,100,000 8. TATA India Pharma & Healthcare Fund
CAGR/Annualized return of 12.3% since its launch. Return for 2024 was 40.4% , 2023 was 36.6% and 2022 was -8% . TATA India Pharma & Healthcare Fund
Growth Launch Date 28 Dec 15 NAV (05 Aug 25) ₹30.52 ↓ -0.06 (-0.20 %) Net Assets (Cr) ₹1,282 on 30 Jun 25 Category Equity - Sectoral AMC Tata Asset Management Limited Rating Risk High Expense Ratio 0 Sharpe Ratio 0.47 Information Ratio 0.73 Alpha Ratio 2.42 Min Investment 5,000 Min SIP Investment 150 Exit Load 0-3 Months (0.25%),3 Months and above(NIL) Growth of 10,000 investment over the years.
Date Value 31 Jul 20 ₹10,000 31 Jul 21 ₹14,231 31 Jul 22 ₹13,103 31 Jul 23 ₹15,890 31 Jul 24 ₹23,208 31 Jul 25 ₹25,061 Returns for TATA India Pharma & Healthcare Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 5 Aug 25 Duration Returns 1 Month -0.5% 3 Month 3.8% 6 Month 1.7% 1 Year 6.2% 3 Year 22.9% 5 Year 19.3% 10 Year 15 Year Since launch 12.3% Historical performance (Yearly) on absolute basis
Year Returns 2024 40.4% 2023 36.6% 2022 -8% 2021 19.1% 2020 64.4% 2019 5.5% 2018 -2.6% 2017 4.7% 2016 -14.7% 2015 Fund Manager information for TATA India Pharma & Healthcare Fund
Name Since Tenure Rajat Srivastava 16 Sep 24 0.87 Yr. Data below for TATA India Pharma & Healthcare Fund as on 30 Jun 25
Equity Sector Allocation
Sector Value Health Care 89.02% Basic Materials 2.34% Financial Services 0.96% Asset Allocation
Asset Class Value Cash 7.68% Equity 92.32% Top Securities Holdings / Portfolio
Name Holding Value Quantity Sun Pharmaceuticals Industries Ltd (Healthcare)
Equity, Since 31 Jan 16 | SUNPHARMA11% ₹143 Cr 854,300 Apollo Hospitals Enterprise Ltd (Healthcare)
Equity, Since 31 Dec 16 | APOLLOHOSP7% ₹92 Cr 127,255
↑ 16,000 Cipla Ltd (Healthcare)
Equity, Since 30 Apr 20 | 5000876% ₹74 Cr 490,000 Divi's Laboratories Ltd (Healthcare)
Equity, Since 30 Sep 17 | DIVISLAB6% ₹71 Cr 104,965 Aurobindo Pharma Ltd (Healthcare)
Equity, Since 30 Apr 20 | AUROPHARMA5% ₹70 Cr 615,100 Fortis Healthcare Ltd (Healthcare)
Equity, Since 31 Oct 20 | 5328435% ₹68 Cr 855,100 Lupin Ltd (Healthcare)
Equity, Since 30 Nov 17 | 5002575% ₹59 Cr 303,240 Aster DM Healthcare Ltd Ordinary Shares (Healthcare)
Equity, Since 31 Dec 22 | 5409754% ₹57 Cr 956,991 Wockhardt Ltd (Healthcare)
Equity, Since 31 Mar 24 | WOCKPHARMA4% ₹47 Cr 274,871 Alkem Laboratories Ltd (Healthcare)
Equity, Since 31 Aug 20 | ALKEM3% ₹37 Cr 75,249 9. IDBI Small Cap Fund
CAGR/Annualized return of 14.5% since its launch. Return for 2024 was 40% , 2023 was 33.4% and 2022 was 2.4% . IDBI Small Cap Fund
Growth Launch Date 21 Jun 17 NAV (05 Aug 25) ₹29.9588 ↓ -0.21 (-0.68 %) Net Assets (Cr) ₹605 on 30 Jun 25 Category Equity - Small Cap AMC IDBI Asset Management Limited Rating Risk Moderately High Expense Ratio 2.3 Sharpe Ratio -0.27 Information Ratio -0.92 Alpha Ratio -7.27 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-12 Months (1%),12 Months and above(NIL) Growth of 10,000 investment over the years.
Date Value 31 Jul 20 ₹10,000 31 Jul 21 ₹19,001 31 Jul 22 ₹21,498 31 Jul 23 ₹26,230 31 Jul 24 ₹40,922 31 Jul 25 ₹38,067 Returns for IDBI Small Cap Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 5 Aug 25 Duration Returns 1 Month -2.1% 3 Month 7.1% 6 Month -2.4% 1 Year -4.1% 3 Year 18.9% 5 Year 29.6% 10 Year 15 Year Since launch 14.5% Historical performance (Yearly) on absolute basis
Year Returns 2024 40% 2023 33.4% 2022 2.4% 2021 64.7% 2020 19% 2019 -4.4% 2018 -15% 2017 2016 2015 Fund Manager information for IDBI Small Cap Fund
Name Since Tenure Nikhil Rungta 1 Jul 24 1.08 Yr. Mahesh Bendre 1 Jul 24 1.08 Yr. Data below for IDBI Small Cap Fund as on 30 Jun 25
Equity Sector Allocation
Sector Value Industrials 35.49% Consumer Cyclical 16.11% Basic Materials 12.59% Consumer Defensive 7.4% Financial Services 7.32% Utility 6.35% Technology 5.13% Health Care 3.57% Communication Services 1.78% Real Estate 0.45% Asset Allocation
Asset Class Value Cash 3.81% Equity 96.19% Top Securities Holdings / Portfolio
Name Holding Value Quantity JTL Industries Ltd (Basic Materials)
Equity, Since 31 Jul 24 | 5346003% ₹20 Cr 2,506,932 Sanathan Textiles Ltd (Consumer Cyclical)
Equity, Since 31 Dec 24 | SANATHAN3% ₹19 Cr 390,711 Manorama Industries Ltd (Consumer Defensive)
Equity, Since 31 Dec 24 | 5419743% ₹16 Cr 109,106 Housing & Urban Development Corp Ltd (Financial Services)
Equity, Since 31 Oct 24 | HUDCO3% ₹16 Cr 668,754 Concord Enviro Systems Ltd (Utilities)
Equity, Since 31 Dec 24 | CEWATER3% ₹16 Cr 270,441 Apollo Micro Systems Ltd Ordinary Shares (Industrials)
Equity, Since 30 Jun 25 | 5408793% ₹15 Cr 877,192
↑ 877,192 Allied Blenders and Distillers Ltd (Consumer Defensive)
Equity, Since 31 Jul 24 | ABDL2% ₹14 Cr 326,140 Enviro Infra Engineers Ltd (Industrials)
Equity, Since 30 Nov 24 | EIEL2% ₹13 Cr 553,566 International Gemmological Institute (India) Ltd (Basic Materials)
Equity, Since 31 Dec 24 | IGIL2% ₹13 Cr 337,832 Exide Industries Ltd (Consumer Cyclical)
Equity, Since 31 Dec 24 | 5000862% ₹12 Cr 321,398 10. L&T Midcap Fund
CAGR/Annualized return of 19% since its launch. Ranked 5 in Mid Cap category. Return for 2024 was 39.7% , 2023 was 40% and 2022 was 1.1% . L&T Midcap Fund
Growth Launch Date 9 Aug 04 NAV (05 Aug 25) ₹388.377 ↑ 0.23 (0.06 %) Net Assets (Cr) ₹12,146 on 30 Jun 25 Category Equity - Mid Cap AMC L&T Investment Management Ltd Rating ☆☆☆☆ Risk High Expense Ratio 1.77 Sharpe Ratio 0.11 Information Ratio -0.28 Alpha Ratio 1.3 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value 31 Jul 20 ₹10,000 31 Jul 21 ₹16,023 31 Jul 22 ₹16,198 31 Jul 23 ₹19,516 31 Jul 24 ₹31,183 31 Jul 25 ₹30,965 Returns for L&T Midcap Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 5 Aug 25 Duration Returns 1 Month -1.2% 3 Month 9.4% 6 Month 9% 1 Year 6% 3 Year 23.8% 5 Year 25.3% 10 Year 15 Year Since launch 19% Historical performance (Yearly) on absolute basis
Year Returns 2024 39.7% 2023 40% 2022 1.1% 2021 30.4% 2020 19% 2019 -0.2% 2018 -12% 2017 52.3% 2016 9.8% 2015 10.8% Fund Manager information for L&T Midcap Fund
Name Since Tenure Cheenu Gupta 26 Nov 22 2.68 Yr. Sonal Gupta 1 Oct 23 1.83 Yr. Data below for L&T Midcap Fund as on 30 Jun 25
Equity Sector Allocation
Sector Value Financial Services 25.76% Industrials 24.4% Consumer Cyclical 16.63% Health Care 10.81% Technology 10.61% Consumer Defensive 3.98% Basic Materials 2.2% Communication Services 1.7% Utility 0.81% Real Estate 0.59% Asset Allocation
Asset Class Value Cash 2.37% Equity 97.63% Top Securities Holdings / Portfolio
Name Holding Value Quantity Max Healthcare Institute Ltd Ordinary Shares (Healthcare)
Equity, Since 30 Sep 21 | MAXHEALTH5% ₹556 Cr 4,355,000 BSE Ltd (Financial Services)
Equity, Since 30 Apr 24 | BSE5% ₹552 Cr 1,994,300 Dixon Technologies (India) Ltd (Technology)
Equity, Since 30 Apr 24 | DIXON4% ₹518 Cr 345,800
↑ 41,000 Jubilant Foodworks Ltd (Consumer Cyclical)
Equity, Since 31 Mar 25 | JUBLFOOD4% ₹488 Cr 6,956,322
↑ 708,322 Eternal Ltd (Consumer Cyclical)
Equity, Since 31 Mar 24 | 5433204% ₹465 Cr 17,596,500 Trent Ltd (Consumer Cyclical)
Equity, Since 30 Jun 19 | 5002513% ₹424 Cr 681,700 GE Vernova T&D India Ltd (Industrials)
Equity, Since 30 Sep 24 | 5222753% ₹415 Cr 1,758,785
↓ -31,545 Nippon Life India Asset Management Ltd Ordinary Shares (Financial Services)
Equity, Since 30 Apr 24 | NAM-INDIA3% ₹415 Cr 5,181,300 Multi Commodity Exchange of India Ltd (Financial Services)
Equity, Since 28 Feb 15 | MCX3% ₹372 Cr 415,447 Persistent Systems Ltd (Technology)
Equity, Since 30 Nov 22 | PERSISTENT3% ₹347 Cr 573,700
ਇੱਥੇ ਪ੍ਰਦਾਨ ਕੀਤੀ ਜਾਣਕਾਰੀ ਨੂੰ ਸਹੀ ਬਣਾਉਣ ਲਈ ਸਾਰੇ ਯਤਨ ਕੀਤੇ ਗਏ ਹਨ. ਹਾਲਾਂਕਿ, ਅੰਕੜਿਆਂ ਦੀ ਸ਼ੁੱਧਤਾ ਦੇ ਸੰਬੰਧ ਵਿੱਚ ਕੋਈ ਗਰੰਟੀ ਨਹੀਂ ਦਿੱਤੀ ਜਾਂਦੀ. ਕਿਰਪਾ ਕਰਕੇ ਕੋਈ ਵੀ ਨਿਵੇਸ਼ ਕਰਨ ਤੋਂ ਪਹਿਲਾਂ ਯੋਜਨਾ ਜਾਣਕਾਰੀ ਦਸਤਾਵੇਜ਼ ਨਾਲ ਜਾਂਚ ਕਰੋ.
AMFI Registration No. 112358 | CIN: U74999MH2016PTC282153
Shepard Technologies Pvt. Ltd. (with ARN code 112358) makes no warranties or representations, express or implied, on products offered through the platform. It accepts no liability for any damages or losses, however caused, in connection with the use of, or on the reliance of its product or related services. Terms and conditions of the website are applicable.
©2025 Shepard Technologies Private Limited. All Rights Reserved